BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20089610)

  • 1. Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions.
    Ortega LM; Schultz DR; Lenz O; Pardo V; Contreras GN
    Lupus; 2010 Apr; 19(5):557-74. PubMed ID: 20089610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus nephritis: a clinical review for practicing nephrologists.
    Contreras G; Roth D; Pardo V; Striker LG; Schultz DR
    Clin Nephrol; 2002 Feb; 57(2):95-107. PubMed ID: 11863131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SLE: Extra-renal clinical manifestations and lupus nephritis].
    Gallelli B; De Angelis V; Ventura D; Meroni PL; Moroni G
    G Ital Nefrol; 2005; 22 Suppl 33():S3-10. PubMed ID: 16419003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
    Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lupus nephritis.
    Dolff S; Berden JH; Bijl M
    Expert Rev Clin Immunol; 2010 Nov; 6(6):901-11. PubMed ID: 20979555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus nephritis.
    Sauter M; Anders HJ
    Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options for resistant lupus nephritis.
    Mok CC
    Semin Arthritis Rheum; 2006 Oct; 36(2):71-81. PubMed ID: 16884971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of lupus nephritis.
    Austin HA; Boumpas DT
    Semin Nephrol; 1996 Nov; 16(6):527-35. PubMed ID: 9125797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options in lupus nephritis.
    McLigeyo SO
    East Afr Med J; 1998 Oct; 75(10):609-13. PubMed ID: 10065198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
    Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history and treatment of lupus nephritis.
    Austin HA; Balow JE
    Semin Nephrol; 1999 Jan; 19(1):2-11. PubMed ID: 9952276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lupus nephritis].
    Morović-Vergles J; Salamon L
    Reumatizam; 2009; 56(2):34-40. PubMed ID: 20429260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
    Demircin G; Oner A; Erdoğan O; Delibaş A; Baysun S; Bülbül M; Bek K; Oksal A
    Ren Fail; 2008; 30(6):603-9. PubMed ID: 18661410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lupus nephritis in children and adolescents: therapy, clinical course and prognosis].
    Bogdanović R; Nikolić V; Ognjanović M; Dimitrijević J; Marković-Lipkovski J; Pasić S; Minić A; Stajić N
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():6-12. PubMed ID: 12583307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of diffuse proliferative lupus nephritis.
    Lim CS; Chin HJ; Jung YC; Kim YS; Ahn C; Han JS; Kim S; Lee JS
    Clin Nephrol; 1999 Sep; 52(3):139-47. PubMed ID: 10499308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lupus nephritis: retrospective analysis of the course of the disease].
    Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.